Nature Communications (Dec 2022)
Tumor fractions deciphered from circulating cell-free DNA methylation for cancer early diagnosis
Abstract
‘Circulating cell-free DNA can be used to predict cancer, but it is more challenging to assess in early stage cancer. Here, the authors created a diagnostic model using tumor fractions deciphered from circulating cfDNA methylation signatures, which exhibited an 86% sensitivity in detecting early-stage cancer.